Laboratory of Pulmonary Pharmacology UPRES EA220, Suresnes, France.
Br J Pharmacol. 2010 Mar;159(6):1304-11. doi: 10.1111/j.1476-5381.2009.00614.x. Epub 2010 Feb 5.
Adenosine is a major endogenous regulator of macrophage function, and activates four specific adenosine receptors (A(1), A(2A), A(2B) and A(3)). Here, we have assessed in human lung macrophages the modulation of the expression of adenosine receptor mRNA by lipopolysaccharide (LPS), and the relative contributions of the different adenosine receptors to LPS-induced production of tumour necrosis factor (TNF)-alpha and chemokines.
Lung macrophages isolated from resected lungs were stimulated with LPS and treated with adenosine receptor agonists or/and antagonists. Adenosine receptor expression was assessed with qRT-PCR. Cytokines were measured in lung macrophage supernatants with elisa.
LPS increased (about 400-fold) mRNA for A(2A) adenosine receptors, decreased mRNA for A(1) and A(2B), but had no effect on A(3) adenosine receptor mRNA. The adenosine receptor agonist NECA inhibited TNF-alpha production concentration dependently, whereas the A(1) receptor agonist, CCPA, and the A(3) receptor agonist, AB-MECA, inhibited TNF-alpha production only at concentrations affecting A(2A) receptors. NECA also inhibited the production of CCL chemokines (CCL2, CCL3, CCL4, CCL5) and CXCL chemokines (CXCL9 and CXCL10), but not that of CXCL1, CXCL8 and CXCL5. Reversal of NECA-induced inhibition of TNF-alpha and chemokine production by the selective A(2A) adenosine receptor antagonist ZM 241385, but not the A(2B) receptor antagonist, MRS 1754, or the A(3) receptor antagonist, MRS 1220, indicated involvement of A(2A) receptors.
LPS up-regulated A(2A) adenosine receptor gene transcription, and this receptor subtype mediated inhibition of the LPS-induced production of TNF-alpha and of a subset of chemokines in human lung macrophages.
腺苷是调节巨噬细胞功能的主要内源性物质,可激活四种特定的腺苷受体(A1、A2A、A2B 和 A3)。在此,我们评估了脂多糖(LPS)对人肺巨噬细胞中腺苷受体 mRNA 表达的调节作用,以及不同腺苷受体对 LPS 诱导的肿瘤坏死因子(TNF)-α和趋化因子产生的相对贡献。
从切除的肺中分离出肺巨噬细胞,用 LPS 刺激,并与腺苷受体激动剂或/和拮抗剂一起处理。用 qRT-PCR 评估腺苷受体表达。用 ELISA 测定肺巨噬细胞上清液中的细胞因子。
LPS 使 A2A 腺苷受体的 mRNA 增加(约 400 倍),使 A1 和 A2B 的 mRNA 减少,但对 A3 腺苷受体的 mRNA 没有影响。腺苷受体激动剂 NECA 呈浓度依赖性地抑制 TNF-α的产生,而 A1 受体激动剂 CCPA 和 A3 受体激动剂 AB-MECA 仅在影响 A2A 受体的浓度下抑制 TNF-α的产生。NECA 还抑制 CCL 趋化因子(CCL2、CCL3、CCL4、CCL5)和 CXCL 趋化因子(CXCL9 和 CXCL10)的产生,但不抑制 CXCL1、CXCL8 和 CXCL5 的产生。选择性 A2A 腺苷受体拮抗剂 ZM 241385逆转了 NECA 诱导的 TNF-α和趋化因子产生的抑制作用,但 A2B 受体拮抗剂 MRS 1754 或 A3 受体拮抗剂 MRS 1220 则没有,表明 A2A 受体参与其中。
LPS 上调了 A2A 腺苷受体基因转录,该受体亚型介导了 LPS 诱导的人肺巨噬细胞中 TNF-α和一组趋化因子产生的抑制作用。